Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2011-06-14
2011-06-14
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S210100, C424S206100, C424S278100
Reexamination Certificate
active
07959931
ABSTRACT:
Antigen and adjuvant components of an adjuvanted influenza vaccine are not mixed during manufacture, but are provided as separate components for extemporaneous mixing at the time of use, for example as a kit comprising (i) an antigen component, comprising an influenza virus antigen; and (ii) an adjuvant component, comprising an aluminium salt.
REFERENCES:
patent: 6372223 (2002-04-01), Kistner et al.
patent: 7238349 (2007-07-01), D'Hondt et al.
patent: WO 00/15251 (2000-03-01), None
patent: WO 01/22992 (2001-04-01), None
Vanselow et al ( Veterinary Record 117: 37-43, 1985; in IDS).
Speidel et al (European Journal of Immunology 27:2391-2399, 1997).
Brady M I et al: “A Surface Antigen Influenza Vaccine Part 2 Pyrogenicity and Antigenicity” Journal of Hygiene, vol. 77, No. 2, 1976, pp. 173-180.
Hehme N et al: “Pandemic preparedness: Lessons learnt from H2N2 and H9N2 candidate vaccines.” Medical Microbiology and Immunology, vol. 191, No. 3-4, Dec. 2002, pp. 2O3-2O8.
Pressler K et al: “Comparison of the Anti Genicity and Tolerance of an Influenza Aluminum Oxide Adsorbate Vaccine With an Aqueous Vaccine” Pharmatherapeutica, vol. 3, No. 3, 1982, pp. 195-200.
Vanselow B A et al: “Bovine Ephemeral Fever Vaccine Incorporating Adjuvant Quil A: A Comparative Study Using Adjuvants Quil A, Aluminium Hydroxide Gel and Dextran Sulphate” Veterinary Record, British Veterinary Association, London, GB, vol. 117, No. 2, Jul. 13, 1985, pp. 37-43.
Zhang C-H et al: “Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared fror F69 strain” Vaccine, Butterworth Scientific, Guildford, GB, vol. 23, No. 24, May 2, 2005, pp. 3196-3201, XP004851707.
Colegate Anthony
Sizer Philip
Gorman Robert
Mosher Mary E
Novartis AG
Riensche Marco
LandOfFree
Influenza vaccines extemporaneously adsorbed to aluminium... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Influenza vaccines extemporaneously adsorbed to aluminium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Influenza vaccines extemporaneously adsorbed to aluminium... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2644704